Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT03736785

Public ClinicalTrials.gov record NCT03736785. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes that have already been treated with basal insulin.

Study identification

NCT ID
NCT03736785
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
399 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 15, 2018 (Actual)
Primary completion
Feb 18, 2020 (Actual)
Completion
Feb 18, 2020 (Actual)
Last update posted
Mar 8, 2021

2018 – 2020

United States locations

U.S. sites
37
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
Central Research Associates, Inc. Birmingham Alabama 35205 —
Arkansas Clinical Research Little Rock Arkansas 72205 —
John Muir Physician Network Clinical Research Center Concord California 94520 —
AMCR Institute INC Escondido California 92025 —
Valley Endocrine, Fresno Fresno California 93720 —
Marin Endocrine Associates Greenbrae California 94904 —
National Research Institute Huntington Park California 90255 —
First Valley Medical Group Lancaster California 93534 —
National Research Institute Los Angeles California 90057 —
University Clinical Investigators, Inc. Tustin California 92780 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
ALL Medical Research, LLC Cooper City Florida 33024 —
Suncoast Clinical Research New Port Richey Florida 34652 —
Metabolic Research Institute Inc. West Palm Beach Florida 33401 —
East West Medical Institute Honolulu Hawaii 96814 —
Elite Clinical Trials LLLP Blackfoot Idaho 83221 —
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404 —
Iderc, P.L.C. West Des Moines Iowa 50265 —
Cotton O'Neil Diabetes and Endocrinology Center Topeka Kansas 66606 —
Endocrine and Metabolic Consultants Rockville Maryland 20852 —
NECCR PrimaCare Research, LLC Fall River Massachusetts 02721 —
Palm Research Center Las Vegas Nevada 89128 —
Palm Research Center Las Vegas Nevada 89148 —
Southern New Hampshire Diabetes and Endocrinology Nashua New Hampshire 03063 —
Metrolina Internal Medicine, P.A. Charlotte North Carolina 28207 —
Intend Research Norman Oklahoma 73069 —
The Corvallis Clinic P.C. Corvallis Oregon 97330 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Preferred Primary Care Physicians - Jacob Murphy Lane Uniontown Pennsylvania 15401 —
Internal Medicine Associates of Anderson Anderson South Carolina 29621 —
The Research Center of the Upstate Mauldin South Carolina 29662 —
Texas Diabetes and Endocrinology Austin Texas 78731-4309 —
Dallas Diabetes Endocrine Center Dallas Texas 75230 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Manassas Clinical Research Center Manassas Virginia 20110 —
Rainier Clinical Research Center Renton Washington 98057 —
Confluence Health Clinical Research Department Wenatchee Washington 98801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03736785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 8, 2021 · Synced Nov 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03736785 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →